NO20082913L - Preservatives which are ERbeta-selective substances, processes for their preparation and pharmaceutical preparations containing these compounds - Google Patents

Preservatives which are ERbeta-selective substances, processes for their preparation and pharmaceutical preparations containing these compounds

Info

Publication number
NO20082913L
NO20082913L NO20082913A NO20082913A NO20082913L NO 20082913 L NO20082913 L NO 20082913L NO 20082913 A NO20082913 A NO 20082913A NO 20082913 A NO20082913 A NO 20082913A NO 20082913 L NO20082913 L NO 20082913L
Authority
NO
Norway
Prior art keywords
compounds
preparation
erbeta
preservatives
processes
Prior art date
Application number
NO20082913A
Other languages
Norwegian (no)
Inventor
Gerd Mueller
Dirk Kosemund
Ralf Wyrwa
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20082913L publication Critical patent/NO20082913L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen angår prolegemidler av 9a-substituerte østratriener av generell formel (I), hvori Z-gruppen er kjedet til et steroid, (I). Oppfinnelsen angår også metoder for fremstilling derav, farmasøytiske preparater som inneholder angitte forbindelser, og anvendelse derav. Angitte, nye forbindelser av generell formel (I) binder ikke med østrogenreseptoren alfa og/eller beta, men de binder med karboanhydraser og inhiberer angitte enzymer.The invention relates to prodrugs of 9a-substituted oestatrienes of general formula (I), wherein the Z group is linked to a steroid, (I). The invention also relates to methods of preparation thereof, pharmaceutical compositions containing specified compounds, and use thereof. Specified novel compounds of general formula (I) do not bind with the estrogen receptor alpha and / or beta, but they bind with carbohydrates and inhibit stated enzymes.

NO20082913A 2005-11-29 2008-06-27 Preservatives which are ERbeta-selective substances, processes for their preparation and pharmaceutical preparations containing these compounds NO20082913L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005057224A DE102005057224A1 (en) 2005-11-29 2005-11-29 New 9-alpha substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders
PCT/EP2006/011729 WO2007062877A2 (en) 2005-11-29 2006-11-27 PRODRUG ERβ-SELECTIVE SUBSTANCES, METHODS FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS

Publications (1)

Publication Number Publication Date
NO20082913L true NO20082913L (en) 2008-07-29

Family

ID=38037824

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082913A NO20082913L (en) 2005-11-29 2008-06-27 Preservatives which are ERbeta-selective substances, processes for their preparation and pharmaceutical preparations containing these compounds

Country Status (14)

Country Link
EP (2) EP1957515A2 (en)
JP (1) JP2009517427A (en)
KR (1) KR20080070839A (en)
CN (1) CN101316857A (en)
AU (1) AU2006319383A1 (en)
BR (1) BRPI0619065A2 (en)
CA (1) CA2629587A1 (en)
CR (1) CR9981A (en)
DE (1) DE102005057224A1 (en)
EA (1) EA200801352A1 (en)
EC (1) ECSP088481A (en)
NO (1) NO20082913L (en)
WO (1) WO2007062877A2 (en)
ZA (1) ZA200805656B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143432A1 (en) 2008-07-11 2010-01-13 Bayer Schering Pharma AG 9-alpha estratriene derivatives as ER-beta selective ligands for the prevention and treatment of intestinal cancer
CN101708338B (en) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 Prodrug containing sterides structures and high dispersion preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813353D0 (en) 1988-06-06 1988-07-13 Ici Plc Therapeutic product
DE19833786A1 (en) 1998-07-18 2000-01-20 Schering Ag New diphenyl-benzocycloheptene derivatives, are tissue-selective estrogens and antiestrogens useful e.g. for treating osteoporosis or hormone-dependent tumors or in hormone replacement therapy
BR0109983A (en) * 2000-04-12 2003-02-25 Schering Ag 8.betahydrocarbyl-substituted stratrienes as selectively efficient estrogens
DE10027887A1 (en) * 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
DE10226326A1 (en) * 2002-06-11 2004-01-15 Schering Ag 9-alpha-substituted estratrienes as selective estrogens
ES2307064T3 (en) * 2003-11-26 2008-11-16 Bayer Schering Pharma Aktiengesellschaft PREVENTION AND TREATMENT OF HYPERTENSIVE CARDIAC DISEASES BY SELECTIVE STROGENS 8BETA-VINIL-ESTRA-1,3,5 (10) -TRIEN-3,17BETA-DIOL AND 17BETA-FLUOR-9ALFA-VINIL-ESTRA-1,3,5 ( 10) -TRIEN-3.16ALFA-DIOL.
DE102004025986A1 (en) * 2004-05-21 2005-12-15 Schering Ag Steroid prodrugs with androgenic effects
DE102004025966A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estradiol prodrugs
DE102004025985A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estriol and estetrol prodrugs

Also Published As

Publication number Publication date
EP2039702A2 (en) 2009-03-25
CA2629587A1 (en) 2007-06-07
WO2007062877A2 (en) 2007-06-07
DE102005057224A1 (en) 2007-05-31
ZA200805656B (en) 2009-11-25
WO2007062877A3 (en) 2007-11-08
ECSP088481A (en) 2008-06-30
KR20080070839A (en) 2008-07-31
JP2009517427A (en) 2009-04-30
EA200801352A1 (en) 2008-10-30
BRPI0619065A2 (en) 2011-09-20
CN101316857A (en) 2008-12-03
CR9981A (en) 2008-09-22
AU2006319383A1 (en) 2007-06-07
EP1957515A2 (en) 2008-08-20

Similar Documents

Publication Publication Date Title
NO20074002L (en) Androgen receptor modulator compounds and methods
NO20082285L (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
NO20070487L (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors.
CL2008001839A1 (en) Compounds derived from 2,7-diazaspirocycles, inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1; pharmaceutical composition comprising said compounds; Useful to treat obesity, diabetes, glucose intolerance, type II diabetes, among other diseases.
NO20090628L (en) Pyridizinone derivatives
BRPI0817096B8 (en) thiazolidinedione analogue and pharmaceutical composition comprising it
NO20081729L (en) New diazaspiroalkanes and their use in the treatment of CCR8-mediated diseases
NO20071901L (en) Substituted bicyclic imidazo-3-ylamine compositions
BRPI0806789B8 (en) compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and, use of a compound or a pharmaceutically acceptable salt thereof
BRPI0922364A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION AND USE OF A COMPOUND
BRPI0810719A8 (en) DIACYLGLYCEROL O-ACETYLTANSFERASE TYPE 1 ENZYME INHIBITORS
MX2009002274A (en) Heterocyclic fxr binding compounds.
WO2008149345A3 (en) Tri-aryl compounds and compositions comprising the same
NO20091626L (en) MGluR5 modulators
BRPI0818893B8 (en) tropane compounds, their pharmaceutical compositions, their uses and in vitro method of inhibiting hsp90 in a cell
NO20092224L (en) Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists
NO20081169L (en) New Camptothecin Analog Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them
NO20092689L (en) Quinuclidinol derivatives as muscarinic receptor antagonists
UA83718C2 (en) Crystalline Form IV of Agomelatine, a METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THIS
NO20092073L (en) C3A receptor modulators, and methods for their use
NO20064160L (en) New azaibicyclic compounds, processes for their preparation and pharmaceutical compositions containing them
BRPI0606964A2 (en) acetylene-derived pyrrolidines and piperidines for use as mglur5 antagonists
JO2770B1 (en) Organic compounds
ZA200801875B (en) Isoquinolines as IGF-IR inhibitors
NO20082913L (en) Preservatives which are ERbeta-selective substances, processes for their preparation and pharmaceutical preparations containing these compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application